Trump given Vaccine made from a mouse REGN-COV2

Trump’s physician, Navy Commander Dr. Sean Conley, revealed on Friday the commander-in-chief received a dose of an experimental antibody cocktail by Regeneron that is in clinical trials. 

Trump is receiving a two-antibody combo drug that’s currently in late-stage studies from Regeneron Pharmaceuticals Inc. The company previously developed a successful treatment for Ebola using a similar approach.

Trump apparently is not receiving hydroxychloroquine (this is from the MSM, so??)

WH press release

https://t.co/cTsXO4Df6b

Excerpt from their website

Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite technologies, such as VelocImmune®, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Also From their website- it’s a damn highly GMO genetic lab created vaccine.

About REGN-COV2

REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19.

To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company's VelocImmune® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19. The two potent, virus-neutralizing antibodies that form REGN-COV2 bind non-competitively to the critical receptor binding domain of the virus's spike protein, which diminishes the ability of mutant viruses to escape treatment and protects against spike variants that have arisen in the human population, as detailed in Science. Preclinical studies have shown that REGN-COV2 reduced the amount of virus and associated damage in the lungs of non-human primates.

REGN-COV2's development and manufacturing has been funded in part with federal funds from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services under OT number: HHSO100201700020C. Regeneron has recently partnered with Roche to increase the global supply of REGN-COV2. If REGN-COV2 proves safe and effective in clinical trials and regulatory approvals are granted, Regeneron will manufacture and distribute it in the U.S. and Roche will develop, manufacture and distribute it outside the U.S.

I've seen multiple medical experts with experience with the drug claim that it can do a whole lot of good, and is highly unlikely to cause any problems.